Parameter | Non-diabetic | Diabetic | ||||
---|---|---|---|---|---|---|
Lean | Overweight | Obese | Lean | Overweight | Obese | |
Total number (N) | 8 | 19 | 22 | 2 | 9 | 31 |
Male (N) | 2 | 12 | 11 | 1 | 5 | 18 |
Female (N) | 6 | 7 | 11 | 1 | 4 | 13 |
Age (years) | 28–53 | 29–71 | 26–66 | 48–58 | 45–59 | 23–72 |
Body mass index (kg/m2) | 23.035 ± 2.326 | 28.31 ± 1.081 | 34.383 ± 2.784 | 25.473 ± 0.338 | 28.130 ± 1.015 | 33.759 ± 2.561 |
Fat percentage (fat %) | 29.757 ± 6.196 | 32.647 ± 4.998 | 39.011 ± 4.350 | 32.100 ± 6.223 | 33.050 ± 5.379 | 37.333 ± 5.035 |
Glucose (mmol/l) | 5.096 ± 0.639 | 5.602 ± 1.559 | 5.424 ± 0.799 | 5.800 ± 0.424 | 8.578 ± 1.770 | 8.640 ± 2.930 |
Cholesterol (mmol/l) | 5.313 ± 1.254 | 4.899 ± 0.773 | 5.233 ± 1.073 | 5.400 ± 2.546 | 4.816 ± 1.681 | 5.065 ± 1.236 |
High-density lipoprotein (mmol/l) | 1.791 ± 0.477 | 1.219 ± 0.225 | 1.115 ± 0.235 | 1.135 ± 0.148 | 1.147 ± 0.411 | 1.129 ± 0.288 |
Low-density lipoprotein (mmol/l) | 3.250 ± 1.046 | 3.147 ± 0.699 | 3.427 ± 0.942 | 3.700 ± 2.121 | 2.767 ± 1.391 | 3.013 ± 1.106 |
Triglycerides (mmol/l) | 0.566 ± 0.216 | 1.215 ± 0.644 | 1.465 ± 0.821 | 1.245 ± 1.252 | 1.972 ± 0.880 | 1.913 ± 1.495 |
HbA1c (%) | 5.688 ± 0.464 | 5.917 ± 1.65 | 5.863 ± 0.497 | 6.000 ± 0.283 | 7.544 ± 1.673 | 8.235 ± 1.506 |
Hypertension (N) | 0 | 2 | 3 | 0 | 3 | 14 |
Hyperlipidemia (N) | 0 | 0 | 2 | 0 | 2 | 3 |
Coronary artery disease (N) | 0 | 0 | 1 | 0 | 1 | 1 |
Allergy (N) | 0 | 0 | 1 | 0 | 0 | 2 |
Asthma (N) | 0 | 1 | 0 | 0 | 0 | 3 |
Therapy | Â | Nadolol, Lipitor, Aspirin | Concor, Lipitor, Aspirin, Diovan | Metfornin, Aspirin | Glucophage, Lipitor, Lantus, Zocor, Diovan, Metformin, Aspirin | NovoRapid, Lantus, Insulin, Aspirin, Concor, Zocor, Mixtard, Glucophage, Metformin, Capoten |